Matthew Oberley/LinkedIn
May 11, 2025, 08:20
Matthew Oberley: Educational Webinar on the Role of IHC in Expanding Potential Targets
Matthew Oberley, Chief Clinical Officer of Caris Life Sciences, shared a post on LinkedIn:
“As the ADC space continues to grow, the role of IHC for patient selection continues to evolve.
Caris Life Sciences has always been ready on day 1 with predictive IHC biomarker testing availability for new FDA approvals!
We will share our experience in this area in this upcoming educational webinar led by our Executive Medical Director David Bryant, MD on existing and upcoming predictive IHC interpretation, clinical utility, and expression prevalence.”
More posts featuring Matthew Oberley.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 17, 2025, 18:57
Jul 17, 2025, 18:43
Jul 17, 2025, 18:15
Jul 17, 2025, 17:56
Jul 17, 2025, 17:44
Jul 17, 2025, 17:40
Jul 17, 2025, 17:19
Jul 17, 2025, 17:12